Answers are grounded in this paper and cite their sources.
Pharmacovigilance analysis highlights safety signals of uveitis in systemic medications, suggesting a need for further investigation.
Multiple systemic agents demonstrated disproportionate uveitis reporting in FAERS. Although these findings do not establish causality, they highlight potential safety signals that warrant continued pharmacovigilance, heightened clinical awareness, and further population-based studies to clarify absolute risk and underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
Butt et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: